GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PeptiDream Inc (TSE:4587) » Definitions » Price-to-Owner-Earnings

PeptiDream (TSE:4587) Price-to-Owner-Earnings : 13.31 (As of May. 24, 2025)


View and export this data going back to 2013. Start your Free Trial

What is PeptiDream Price-to-Owner-Earnings?

As of today (2025-05-24), PeptiDream's share price is 円1673.50. PeptiDream's Owner Earnings per Share (TTM) ended in Mar. 2025 was 円125.71. It's Price-to-Owner-Earnings for today is 13.31.


The historical rank and industry rank for PeptiDream's Price-to-Owner-Earnings or its related term are showing as below:

TSE:4587' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 10.73   Med: 191.78   Max: 371428.57
Current: 13.31

During the past 13 years, the highest Price-to-Owner-Earnings of PeptiDream was 371428.57. The lowest was 10.73. And the median was 191.78.


TSE:4587's Price-to-Owner-Earnings is ranked better than
76.11% of 180 companies
in the Biotechnology industry
Industry Median: 28.53 vs TSE:4587: 13.31

As of today (2025-05-24), PeptiDream's share price is 円1673.50. PeptiDream's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was 円114.20. Therefore, PeptiDream's PE Ratio (TTM) for today is 14.65.

As of today (2025-05-24), PeptiDream's share price is 円1673.50. PeptiDream's EPS without NRI for the trailing twelve months (TTM) ended in was 円114.20. Therefore, PeptiDream's PE Ratio without NRI for today is 14.65.

During the past 13 years, PeptiDream's highest PE Ratio without NRI was 4053.74. The lowest was 12.70. And the median was 188.39.


PeptiDream Price-to-Owner-Earnings Historical Data

The historical data trend for PeptiDream's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PeptiDream Price-to-Owner-Earnings Chart

PeptiDream Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 51.27 - 13.00 20.78

PeptiDream Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.15 - 16.70 20.78 17.32

Competitive Comparison of PeptiDream's Price-to-Owner-Earnings

For the Biotechnology subindustry, PeptiDream's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PeptiDream's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PeptiDream's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where PeptiDream's Price-to-Owner-Earnings falls into.


;
;

PeptiDream Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

PeptiDream's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1673.50/125.71
=13.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PeptiDream  (TSE:4587) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


PeptiDream Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of PeptiDream's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


PeptiDream Business Description

Traded in Other Exchanges
Address
1-2-10, Nihonbashi, Chuo-ku, Toyo Building, 6th Floor, Tokyo, JPN, 103-0027
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.

PeptiDream Headlines

No Headlines